Clinical Trials Directory

Trials / Completed

CompletedNCT00306683

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Clinical Assessment of the Treatment With Diazoxide in Children Suffering From Obesity and Hyperinsulinemia Secondary to Surgery of Hypothalamic-pituitary Lesions

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

In children treated for intracranial lesions, the 2 factors of the obesity are : the location of the lesion (hypothalamic-pituitary region) and craniopharyngiomas

Detailed description

Approximately 80 % of the hypothalamic-pituitary lesions that occur in children are craniopharyngiomas with one or three cases per 1 million children each year. One major problem remains unsolved : the obesity This study is performed to optimize the management of the children with hypothalamic-pituitary lesions by reducing the hyperinsulinemia due to the lesion and the surgery

Conditions

Interventions

TypeNameDescription
DRUGDIAZOXIDE

Timeline

Start date
2006-04-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2006-03-24
Last updated
2011-02-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00306683. Inclusion in this directory is not an endorsement.